KVUE
NYSE Kenvue, Inc.$17.73 ↑ +0.14 (+0.80%) Trading Up from the previous close of $17.59
- YTD change
- +2.78%
- vs 20-day SMA
- +0.14%
- vs 200-day SMA
- -1.70%
Price ranges
Price & Performance
+0.86 (+5.14%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 36.2% away from all-time highs of $27.80
- KVUE is up 3% since the beginning of the year
- KVUE is up 9% over the past 12 months
- KVUE is down 4% over the past 1 month
- 3% of all KVUE investors are betting against KVUE
- Number of investors short KVUE has gone down 20% versus last month
KVUE reads very good: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +8.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.21
- Last 5 days
- -1.01%
- vs 8-day SMA
- +0.85%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
